Understanding chromosome aberrations through cytogenomic analysis is an integral part of current genomic medicine, playing a role in both constitutional disorders and cancer. At Illumina, we collaborate with industry experts, thought leaders, and customers to develop solutions to meet your evolving needs. Now you can perform sequencing and high-quality cytogenomic array scanning all on a single platform.
Next-generation sequencing (NGS) offers detection that complements arrays. Together, the two methods are ideal across a spectrum of reproductive and genetic health applications.
Now you can perform sequencing and high-quality cytogenomic array scanning all on a single system, the NextSeq 550 System. Advance your research with the flexible power of this system.The BeadChip array adapter enables array scanning on the new system.
Traditional molecular cytogenomic methods for assessing chromosomal abnormalities, including FISH and karyotyping, enable genome visualization, but often at a low resolution. As a result, data from these methods can often be inconsistent.
Cytogenomic microarrays offer a simpler, more reliable method for assessing chromosomal aberrations at a higher resolution.
Illumina offers industry-leading chromosomal microarrays designed to detect chromosome aberrations and provide accurate, reliable cytogenomic data with:
BlueFuse Multi Software provides molecular cytogenetic and in vitro fertilization (IVF) data analysis in a single framework.
Perform sequencing and high-quality cytogenomic array scanning all on a single system, the NextSeq 550 System.
Read Data Sheet (PDF) »
Learn more about how NGS is transforming research.
Read Introduction (PDF) »
iScan offers a dramatic reduction in microarray scanning time.
View System »
Trilochan Sahoo, MD discusses the benefits of the CytoSNP-850K BeadChip array.
Read Interview (PDF) »